Ulcer News and Research RSS Feed - Ulcer News and Research

Twenty-five million Americans suffer from ulcers. An ulcer is a sore or hole in the lining of the stomach or duodenum (the first part of the small intestine). People of any age can get an ulcer and women are affected just as often as men.

Helicobacter pylori (H. pylori) is a bacterium that lives on the lining of the stomach. Although we used to think that spicy food, acid, and stress were the major causes of ulcers, we now know that nine out of ten ulcers are caused by H. pylori. Medicines that reduce stomach acid may make you feel better, but your ulcer may come back. Here's the good news: Since most ulcers are caused by this bacterial infection, they can be cured with the right antibiotics.
WHO urges affected countries to increase investment in tackling neglected tropical diseases

WHO urges affected countries to increase investment in tackling neglected tropical diseases

WHO urges affected countries to scale up their investment in tackling 17 neglected tropical diseases in order to improve the health and well-being of more than 1.5 billion people. This investment would represent as little as 0.1% of current domestic expenditure on health in affected low and middle income countries for the period 2015-2030. [More]
Leaf Healthcare's wireless patient monitoring system can improve pressure ulcer prevention processes

Leaf Healthcare's wireless patient monitoring system can improve pressure ulcer prevention processes

Clinicians from the Veterans Affairs Medical Center in Boise, Idaho, will demonstrate that Leaf Healthcare's new, wireless patient monitoring system can significantly improve a caregiver's pressure ulcer prevention processes. Their presentation will take place at the National Pressure Ulcer Advisory Panel Biennial Conference in Orlando, Fla., this week. [More]
Advances in stem cell therapy can improve outcomes for patients with chronic diabetic foot ulcers

Advances in stem cell therapy can improve outcomes for patients with chronic diabetic foot ulcers

According to data presented at the 73rd Annual Scientific Conference of the American College of Foot and Ankle Surgeons, advances in stem cell therapy can significantly improve outcomes for patients with chronic diabetic foot ulcers. Use of stem cells to treat foot problems like diabetic ulcers may speed up the healing process, preventing infection and hospitalization during recovery. [More]
Cumberland initiates clinical development of Boxaban (ifetroban) oral capsule for AERD treatment

Cumberland initiates clinical development of Boxaban (ifetroban) oral capsule for AERD treatment

Cumberland Pharmaceuticals Inc. today announced an expansion of its pipeline with a new Phase II development program. The Company has initiated the clinical development of Boxaban (ifetroban) oral capsule for the treatment of aspirin-exacerbated respiratory disease (AERD). [More]
Stomach ulcer bug H. pylori may reduce risk of developing multiple sclerosis

Stomach ulcer bug H. pylori may reduce risk of developing multiple sclerosis

A West Australian team has found evidence that the stomach ulcer bacterium, Helicobacter pylori, is associated with a lower risk of multiple sclerosis (MS), bolstering evidence for the role of the ‘hygiene hypothesis’ in autoimmune disorders. [More]
FDA approves RYTARY for Parkinson's disease treatment

FDA approves RYTARY for Parkinson's disease treatment

Impax Pharmaceuticals, a division of Impax Laboratories, Inc., today announced that the U.S. Food and Drug Administration approved RYTARY, an extended-release oral capsule formulation of carbidopa-levodopa, for the treatment of Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism that may follow carbon monoxide intoxication and / or manganese intoxication. [More]
FDA approves Hospira's Dyloject (diclofenac sodium) Injection for pain management

FDA approves Hospira's Dyloject (diclofenac sodium) Injection for pain management

Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, has received approval from the U.S. Food and Drug Administration for Dyloject (diclofenac sodium) Injection, a proprietary nonsteroidal anti-inflammatory drug (NSAID) analgesic. [More]

Joerns RecoverCare introduces unique mattress coverlet system to support wound care

Joerns RecoverCare has launched ClimateCare; a unique mattress coverlet system that provides microclimate management. When used in conjunction with a pressure redistribution mattress, ClimateCare is designed to address the root causes of tissue breakdown through the management of temperature and moisture (microclimate) at the interface between the patient's skin and the therapy support surface. [More]
Minnesota hospitals prevent patient harms, save $93 million in health spending

Minnesota hospitals prevent patient harms, save $93 million in health spending

Minnesota hospitals and health systems have prevented more than 12,000 patients from being harmed and saved more than $93 million as a result of a reduction in hospital-acquired conditions from 2010-13. Nationwide, hospitals prevented 1.3 million patient harms and saved more than $12 billion in health spending, according to a report issued today by the U.S. Department of Health and Human Services. [More]

University of Melbourne researcher explores impact of living with chronic wounds

People who live with chronic wounds are often disadvantaged financially and emotionally and remain a hidden aspect of our healthcare system. [More]
Regenerative medicine may offer new standard of advanced treatment for foot and leg ulcers

Regenerative medicine may offer new standard of advanced treatment for foot and leg ulcers

These are exciting times for regenerative medicine. Unlike conventional medicines, the regenerative approach can potentially work to restore the lost functionality of tissues or organs—the major reason for intensive focus on research and development in the field. [More]
Dual intragastric balloon procedure shows promise for people with obesity

Dual intragastric balloon procedure shows promise for people with obesity

After six months, people with intragastric balloons in their stomachs lost more than twice their excess weight, compared to people who tried to lose weight under a medically supervised diet and exercise program alone, according to new research from a randomized clinical trial presented here at ObesityWeek 2014, the largest international event focused on the basic science, clinical application and prevention and treatment of obesity. [More]
Study highlights connections between climate change and new outbreak of diseases

Study highlights connections between climate change and new outbreak of diseases

Climate change may affect human health directly or indirectly. In addition to increased threats of storms, flooding, droughts, and heat waves, other health risks are being identified. In particular, new diseases are appearing, caused by infectious agents (viruses, bacteria, parasites) heretofore unknown or that are changing, especially under the effect of changes in the climate (change of host, vector, pathogenicity, or strain). [More]
Glenmark gets final approval from FDA for Omeprazole DR Capsules ANDA

Glenmark gets final approval from FDA for Omeprazole DR Capsules ANDA

Glenmark Generics Inc. USA, the subsidiary of Glenmark Generics Limited, has been granted final approval for its abbreviated new drug application (ANDA) from the United States Food and Drug Administration for Omeprazole Delayed Release Capsules, their generic version of Prilosec by AstraZeneca. [More]
Infection with herpes simplex virus increases Alzheimer's risk

Infection with herpes simplex virus increases Alzheimer's risk

Infection with herpes simplex virus increases the risk of Alzheimer's disease. Researchers at Umeå University, Sweden, claim this in two studies in the journal Alzheimer's & Dementia. [More]
Ebola outbreak emphasizes the importance of monitoring disease burden in developing countries

Ebola outbreak emphasizes the importance of monitoring disease burden in developing countries

A study recently published in the Journal of the American Academy of Dermatology shows that for Ebola, measles, syphilis and many other conditions with skin manifestations the mortality rates are hundreds of times higher in developing countries than they are in developed countries. [More]
Preoperative IV ibuprofen improves quality of recovery after laparoscopic cholecystectomy surgery

Preoperative IV ibuprofen improves quality of recovery after laparoscopic cholecystectomy surgery

Cumberland Pharmaceuticals Inc. today announced that preoperative intravenous ibuprofen improved overall quality of recovery in patients undergoing laparoscopic cholecystectomy surgery. These results will be presented at the American Anesthesiology 2014 Annual Meeting in New Orleans, Louisiana. [More]
Chronic contact allergy from metal orthopedic implant linked to aggressive form of skin cancer

Chronic contact allergy from metal orthopedic implant linked to aggressive form of skin cancer

In rare cases, patients with allergies to metals develop persistent skin rashes after metal devices are implanted near the skin. New research suggests these patients may be at increased risk of an unusual and aggressive form of skin cancer. [More]
Now, women experiencing morning sickness can benefit from Diclegis drug

Now, women experiencing morning sickness can benefit from Diclegis drug

Up to 85 percent of pregnant women are affected by nausea and vomiting of pregnancy (NVP), more commonly known as morning sickness. [More]
Actavis reports positive results from ceftazidime-avibactam Phase III studies in cIAI patients

Actavis reports positive results from ceftazidime-avibactam Phase III studies in cIAI patients

Actavis plc today confirmed positive topline results from RECLAIM-1 and -2, pivotal Phase III studies evaluating the potential for the investigational antibiotic, ceftazidime-avibactam as a treatment for adult hospitalized patients with complicated intra-abdominal infections. [More]